Literature DB >> 15632012

Cellular response of cardiac fibroblasts to amyloidogenic light chains.

Vickery Trinkaus-Randall1, Mary T Walsh, Shawn Steeves, Grace Monis, Lawreen H Connors, Martha Skinner.   

Abstract

Amyloidoses are a group of disorders characterized by abnormal folding of proteins that impair organ function. We investigated the cellular response of primary cardiac fibroblasts to amyloidogenic light chains and determined the corresponding change in proteoglycan expression and localization. The cellular response to 11 urinary immunoglobulin light chains of kappa1, lambda6, and lambda 3 subtypes was evaluated. The localization of the light chains was monitored by conjugating them to Oregon Green 488 and performing live cell confocal microscopy. Sulfation of the proteoglycans was determined after elution over Q1-columns with a single-step salt gradient (1.5 mol/L NaCl) via dimethylmethylene blue. Light chains were detected inside cells within 4 hours and demonstrated perinuclear localization. Over 80% of the cells showed intracellular localization of the amyloid light chains. The light chains induced sulfation of the secreted glycosaminoglycans, but the cell fraction possessed only minimal sulfation. Furthermore, the light chains caused a translocation of heparan sulfate proteoglycan to the nucleus. The conformation and thermal stability of light chains was altered when they were incubated in the presence of heparan sulfate and destabilization of the amyloid light chains was detected. These studies indicate that internalization of the light chains mediates the expression and localization of heparan sulfate proteoglycans.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15632012      PMCID: PMC1602293          DOI: 10.1016/S0002-9440(10)62244-4

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  46 in total

Review 1.  Immunoglobulin light chains, glycosaminoglycans, and amyloid.

Authors:  F J Stevens; R Kisilevsky
Journal:  Cell Mol Life Sci       Date:  2000-03       Impact factor: 9.261

2.  Identification and location of a cysteinyl posttranslational modification in an amyloidogenic kappa1 light chain protein by electrospray ionization and matrix-assisted laser desorption/ionization mass spectrometry.

Authors:  A Lim; J Wally; M T Walsh; M Skinner; C E Costello
Journal:  Anal Biochem       Date:  2001-08-01       Impact factor: 3.365

3.  Biophysical analysis of normal transthyretin: implications for fibril formation in senile systemic amyloidosis.

Authors:  C M Chung; L H Connors; M D Benson; M T Walsh
Journal:  Amyloid       Date:  2001-06       Impact factor: 7.141

4.  Overproduction of perlecan core protein in cultured cells and transgenic mice.

Authors:  M Hart; L Li; T Tokunaga; J R Lindsey; J R Hassell; A D Snow; K Fukuchi
Journal:  J Pathol       Date:  2001-06       Impact factor: 7.996

5.  Identification of a heparin binding domain in the N-terminal cleavage site of pro-islet amyloid polypeptide. Implications for islet amyloid formation.

Authors:  K Park; C B Verchere
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

6.  Role of epidermal growth factor and epidermal growth factor receptor on hemidesmosome complex formation and integrin subunit beta4.

Authors:  Q H Song; H Gong; V Trinkaus-Randall
Journal:  Cell Tissue Res       Date:  2003-04-25       Impact factor: 5.249

7.  Effect of poly(vinylsulfonate) on murine AA amyloid: a high-resolution ultrastructural study.

Authors:  S Inoue; P G Hultin; W A Szarek; R Kisilevsky
Journal:  Lab Invest       Date:  1996-06       Impact factor: 5.662

8.  Nuclear localization of basic fibroblast growth factor is mediated by heparan sulfate proteoglycans through protein kinase C signaling.

Authors:  Edward Hsia; Thomas P Richardson; Matthew A Nugent
Journal:  J Cell Biochem       Date:  2003-04-15       Impact factor: 4.429

9.  Short-chain aliphatic polysulfonates inhibit the entry of Plasmodium into red blood cells.

Authors:  Robert Kisilevsky; Ian Crandall; Walter A Szarek; Shridhar Bhat; Christopher Tan; Lee Boudreau; Kevin C Kain
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

10.  Regulation of heparan sulfate proteoglycan nuclear localization by fibronectin.

Authors:  T P Richardson; V Trinkaus-Randall; M A Nugent
Journal:  J Cell Sci       Date:  2001-05       Impact factor: 5.285

View more
  20 in total

1.  The effects of sodium sulfate, glycosaminoglycans, and Congo red on the structure, stability, and amyloid formation of an immunoglobulin light-chain protein.

Authors:  Richard W McLaughlin; Janelle K De Stigter; Laura A Sikkink; Elizabeth M Baden; Marina Ramirez-Alvarado
Journal:  Protein Sci       Date:  2006-06-02       Impact factor: 6.725

Review 2.  Sulfated glycosaminoglycans in protein aggregation diseases.

Authors:  Kazuchika Nishitsuji; Kenji Uchimura
Journal:  Glycoconj J       Date:  2017-04-11       Impact factor: 2.916

3.  Role of glycosaminoglycan sulfation in the formation of immunoglobulin light chain amyloid oligomers and fibrils.

Authors:  Ruiyi Ren; Zhenning Hong; Haiyan Gong; Kate Laporte; Martha Skinner; David C Seldin; Catherine E Costello; Lawreen H Connors; Vickery Trinkaus-Randall
Journal:  J Biol Chem       Date:  2010-09-24       Impact factor: 5.157

4.  The effect of membranes on the in vitro fibrillation of an amyloidogenic light-chain variable-domain SMA.

Authors:  Xiaoyun Meng; Anthony L Fink; Vladimir N Uversky
Journal:  J Mol Biol       Date:  2008-06-28       Impact factor: 5.469

Review 5.  New insights and modern treatment of AL amyloidosis.

Authors:  Chakra P Chaulagain; Raymond L Comenzo
Journal:  Curr Hematol Malig Rep       Date:  2013-12       Impact factor: 3.952

6.  Pre-transplantation novel agent induction predicts progression-free survival for patients with immunoglobulin light-chain amyloidosis undergoing high-dose melphalan and autologous stem cell transplantation.

Authors:  Andrew J Cowan; Zandra K Klippel; Philip A Stevenson; Teresa S Hyun; Sherilyn Tuazon; Pamela S Becker; Damian J Green; Leona A Holmberg; David G Coffey; Ajay K Gopal; Edward N Libby
Journal:  Amyloid       Date:  2016-11-23       Impact factor: 7.141

7.  Biologic and genetic characterization of the novel amyloidogenic lambda light chain-secreting human cell lines, ALMC-1 and ALMC-2.

Authors:  Bonnie K Arendt; Marina Ramirez-Alvarado; Laura A Sikkink; Jonathan J Keats; Gregory J Ahmann; Angela Dispenzieri; Rafael Fonseca; Rhett P Ketterling; Ryan A Knudson; Erin M Mulvihill; Renee C Tschumper; Xiaosheng Wu; Steven R Zeldenrust; Diane F Jelinek
Journal:  Blood       Date:  2008-06-20       Impact factor: 22.113

8.  Cell Damage in Light Chain Amyloidosis: FIBRIL INTERNALIZATION, TOXICITY AND CELL-MEDIATED SEEDING.

Authors:  Marta Marin-Argany; Yi Lin; Pinaki Misra; Angela Williams; Jonathan S Wall; Kyle G Howell; Laura R Elsbernd; Megan McClure; Marina Ramirez-Alvarado
Journal:  J Biol Chem       Date:  2016-07-26       Impact factor: 5.157

Review 9.  Amyloid formation in light chain amyloidosis.

Authors:  Marina Ramirez-Alvarado
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

10.  Light chain amyloidosis - current findings and future prospects.

Authors:  Elizabeth M Baden; Laura A Sikkink; Marina Ramirez-Alvarado
Journal:  Curr Protein Pept Sci       Date:  2009-10       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.